Table 3. Adjusted meningioma fasting hazard ratiosa for serum biomarkers by time before diagnosis, death or censoring.

Fasting hazard ratios (95% confidence intervals)
Time before diagnosis	⩽1 year	>1-⩽5 years	>5-⩽10 years	>10-⩽15 years
Glucoseb
Women	0.50 (0.21-1.18)	0.72 (0.46-1.13)	0.90 (0.62-1.31)	0.34 (0.22-0.54)
Men	1.06 (0.57-1.98)	1.09 (0.75-1.57)	1.14 (0.84-1.55)	0.82 (0.53-1.29)
Total	0.76 (0.43-1.35)	0.90 (0.67-1.20)	1.05 (0.84-1.31)	0.61 (0.50-0.75)
Cholesterolb
Women	0.65 (0.38-1.11)	0.96 (0.70-1.33)	0.95 (0.71-1.28)	1.07 (0.78-1.45)
Men	0.40c (0.26-0.62)	0.84 (0.56-1.26)	1.02 (0.73-1.42)	0.82 (0.55-1.21)
Total	0.50 (0.34-0.72)	0.91 (0.71-1.17)	0.95 (0.77-1.18)	0.95 (0.74-1.22)
Number of cases
Women	24	47	46	64
Men	16	24	38	37
Total	40	71	84	101

^aHazard ratios adjusted for age and date of laboratory test, triglycerides, and other serum biomarkers in the table.

^bBiomarkers were transformed to their standardised logs. One unit of this transformed biomarker value equals one standard deviation.

^cA hazard ratio of 0.40 indicates that a one unit increase in the standardised log of cholesterol corresponds to a 60% decrease in the meningioma hazard rate.